Market Cap (In PLN)
130.81 Million
Revenue (In PLN)
-
Net Income (In PLN)
-5.58 Million
Avg. Volume
131.00
- Currency
- PLN
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 73.0-112.5
- PE
- -
- EPS
- -
- Beta Value
- 0.134
- ISIN
- PLURTST00010
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Grzegorz Stefanski
- Employee Count
- -
- Website
- https://www.urteste.com
- Ipo Date
- 2021-10-27
- Details
- Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
More Stocks
-
DIISF
-
BCB
-
688567
-
AP4
-
GRSFF
-
FPH
-
BRGBorregaard ASA
BRG
-
603030